Search for: "Broc Romanek" Results 581 - 600 of 2,152
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Mar 2016, 3:34 am by Broc Romanek
I’ve been posting memos on Sanofi in our “Securities Litigation” Practice Area… – Broc Romanek [read post]
16 Jan 2014, 4:06 am by Broc Romanek
Here are some of the latest entries: - Report: Fortunate Executive Stock Sales & Earnings Guidance - The Equity Facade Of SEC Disgorgement - Comparison: Director & Investor Viewpoints - Report: More Audit Committee Transparency Encouraged - DOL's Electronic Delivery Guidance: Struggling to Go Forward - Broc Romanek [read post]
24 Jun 2013, 4:54 am by Broc Romanek
- Goldman Sachs to Enhance Lead Director Duties in Deal with CtW - Broc Romanek [read post]
24 Jul 2013, 3:46 am by Broc Romanek
Novell: The Latest Adventures of the Business Judgment Rule - Survey: JOBS Act Has No Major Impact on IPO Market (So Far) - Broc Romanek [read post]
29 Oct 2014, 4:23 am by Broc Romanek
Cap’n Cashbags: Time to Grant Stock Options In this 20-second video, Cap’n Cashbags – a CEO – is hoping to get his mega-grant of stock options soon: – Broc Romanek [read post]
28 Jul 2014, 3:52 am by Broc Romanek
In the first example below, note that Oracle/Micros has a covenant that the seller has undertaken commercially reasonable efforts to eliminate conflict minerals from its supply chain: - Oracle/Micros (covenant in Section 5.23) - Allergan/MAP Pharmaceuticals (see Section 3.29) - Valeant/OBAGI Medical (see Section 4.5) - Met-Pro/CECO Environmental (see Section 4.7(e)) - Citrix Systems/Bytemobile (see Section 2.32) - Salix Pharmaceuticals/Santarus (see Section 5.26) - Broc Romanek [read post]
11 Feb 2011, 3:48 am by Broc Romanek
National Australia Bank, Southern District of New York Court Weighs In - Ten Country Interagency Report on Boards and Risk Management - A Disclaimer Too Far - Risks, Compliance, the SEC and New Concerns for Directors - Broc Romanek [read post]